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Background: Inflammatory bowel diseases are associated with increased expression of zinc-dependent Matrix
Metalloproteinase 9 (MMP-9). A stark dysregulation of intestinal mucosal homeostasis has been observed in patients
with chronic inflammatory bowel diseases. We therefore sought to determine the contribution of MMP-9 to the
pathogenesis of Citrobacter rodentium-induced colitis and its effects on gut microbiome homeostasis.
Results: Wild-type and MMP-9−/− mice aged 5–6 weeks were challenged with C. rodentium by orogastric gavage
and sacrificed either 10 or 30 days post-infection. Disease severity was assessed by histological analysis of colonic
epithelial hyperplasia and by using an in vivo intestinal permeability assay. Changes in the inflammatory responses
were measured by using qPCR, and the composition of the fecal microbiome evaluated with both qPCR and
terminal restriction fragment length polymorphism. Activation and localization of MMP-9 to the apical surface of
the colonic epithelium in response to C. rodentium infection was demonstrated by both zymography and
immunocytochemistry. The pro-inflammatory response to infection, including colonic epithelial cell hyperplasia and
barrier dysfunction, was similar, irrespective of genotype. Nonmetric multidimensional scaling of terminal restriction
fragments revealed a different fecal microbiome composition and C. rodentium colonization pattern between
genotypes, with MMP-9−/− having elevated levels of protective segmented filamentous bacteria and interleukin-17,
and lower levels of C. rodentium. MMP-9−/− but not wild-type mice were also protected from reductions in fecal
microbial diversity in response to the bacterial enteric infection.
Conclusions: These results demonstrate that MMP-9 expression in the colon causes alterations in the fecal
microbiome and has an impact on the pathogenesis of bacterial-induced colitis in mice.Background
Microbe-microbe and host-microbe interactions combine
to maintain intestinal homeostasis and proper functioning
of the gut, including immunomodulation and intestinal epi-
thelial barrier function [1]. The contribution of specific
interactions, including cooperation and competition at the
microbe-microbe level, is still not well characterized. How-
ever, an in vivomesocosm model has revealed the dynamics
of a simple gut microbial community consisting of Lactoba-
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reproduction in any medium, provided the orcoli [2]. Host-microbe interactions have been studied
more intensely under both physiological and pathological
conditions, including the contribution of mucins, anti-
microbial peptides and secretory antibodies in maintain-
ing gut homeostasis. In healthy individuals, these
interactions combine to produce a fecal microbiota of
notable stability [3] that is in stark contrast to the dysre-
gulation of intestinal mucosal homeostasis observed in
patients with chronic inflammatory bowel diseases (IBD)
[1]. Through analysis of the fecal microbiota in patients
with Crohn disease, a microbial signature has been
described for the disease state, compared to unaffected
relatives [4].
There is evidence that the chronic consequences of
enterohemorrhagic Escherichia coli (EHEC) serotype
O157:H7 infection, which causes bloody diarrhea andral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 C. rodentium infection is associated with increased
MMP-9 activation. (A) Representative gelatin zymogram showing
the absence of MMP-9 activity in sham-infected animals and
activation of MMP-9 at 10d PI with C. rodentium. Positive controls for
MMP-9 were obtained from colonic homogenates from dextran
sodium sulphate (DSS)-treated animals, at the peak of inflammation
(8d post-DSS). (B) Representative western blot demonstrates
increased activation of MMP-9 (92 kDa) in whole colon
homogenates obtained from C. rodentium-infected WT and
MMP-9−/− mice at 10 days PI, compared to sham-infected mice.
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dysbiosis which then contributes to the chronic symp-
toms that characterize post-infectious irritable bowel
syndrome (IBS) [6] and chronic IBD [7]. Citrobacter
rodentium is a murine-specific enteric pathogen genetic-
ally related to EHEC that is capable of causing similar
dysregulation of intestinal mucosal homeostasis in a
mouse model of colitis. Infection with C. rodentium
results in a decrease in microbial diversity and an
inflammatory response in the colon of infected mice [8].
Pathogenicity of both EHEC and C. rodentium is attribu-
ted to locus of enterocyte effacement (LEE) and non-
LEE type III effector proteins, which mediate host
responses to infection. The host response to infection is
characterized by increases in T helper (TH)-1 and TH-17
cells, colonic epithelial cell hyperplasia and mucosal
barrier dysfunction [9].
The matrix metalloproteinase (MMP) family consists
of 24 zinc-dependent proteases, which are secreted as
inactive zymogens by many cell types including proin-
flammatory cells, fibroblasts and epithelial cells.
Increased expression of MMPs −1, -2, -3, -8, -9, and −12
each have been associated with IBD [10–12]. Individual
MMPs vary in substrate specificity, and may have mul-
tiple substrates for which they are biologically active.
These proteases are involved in multiple biological pro-
cesses, including extracellular matrix remodeling [13],
protein maturation [14] and bactericidal activity [15].
Other proteases are also implicated in the establish-
ment of infectious colitis, as serine protease inhibitors
can lessen the severity of C. rodentium-induced colitis
[16]. In other animal models of IBD, MMP-9 is indispen-
sible for establishment of inflammation in the dextran
sodium sulphate (DSS) colitis model [17] through sup-
pression of epithelial wound healing and goblet cell
differentiation [18]. However, relationships between dis-
ease severity, the activation of specific MMPs and altera-
tions in gut microbial diversity have not been fully
determined. Therefore, the aim of this study was to
determine the contribution of MMP-9 to the pathogen-
esis of C. rodentium infection and its influence on
microbial diversity in the gut.
Results
MMP-9 is upregulated in the colon of wild-type mice
10 days post infection with C. rodentium and localizes at
the apical surface of the colonic epithelium
To determine whether MMP-9 was involved in the
pathogenesis of C. rodentium infection, protein expres-
sion and bioactivity were assessed in whole colon homo-
genates obtained from both uninfected and infected
mice. Gelatin zymography was utilized to determine if
MMP-9 was able to cleave gelatin, a physiological sub-
strate of this protease [19]. Zymographic analysisrevealed a band of gelatin digestion at 92kD in colon
homogenates from mice 10 days after challenge with C.
rodentium (Figure 1A), which was comparable to a posi-
tive control used for MMP-9 activity (DSS-treated
mouse colon). The band was absent in zymograms rena-
tured and incubated with 20 mM EDTA, reinforcing that
this band is a metalloprotease (data not shown). Taken
together, these data show that bioactive MMP-9 is not
expressed normally in mouse colon, but protease expres-
sion is upregulated in response to an infectious colitis.
In addition, immunoblotting revealed the presence of a
92kD MMP-9 immunoreactive band in the infected sam-
ples that was undetectable in both uninfected controls
and infected MMP-9−/− mice (Figure 1B).
MMP-9−/− and wild-type C. rodentium-infected mice
display similar colonic epithelial hyperplastic responses
and changes in barrier dysfunction
MMP-9−/− mice were used to determine a possible contri-
bution of MMP-9 in the pathogenesis of C. rodentium-
Rodrigues et al. BMC Microbiology 2012, 12:105 Page 3 of 13
http://www.biomedcentral.com/1471-2180/12/105infection. Both wild-type (WT) and MMP-9−/− mice
demonstrated hyperplastic responses to C. rodentium at
10 days post infection (PI) (Figure 2A), with the degree
of hyperplasia comparable between the two groups dur-
ing this peak phase of inflammation (Figure 2B)
(P> 0.05). At 30 days PI, when the overt inflammatory
response has ceased [9,20], epithelial hyperplasia
remained elevated in both groups of infected mice
(P< 0.05).
To investigate the presence of deficits in epithelial bar-
rier function, WT and MMP-9−/− mice were orogastri-
cally gavaged with FITC-labeled dextran probe (4 kDa).
Although dextran flux does not localize the source of
macro-molecular uptake along the length of the gastro-
intestinal tract, the probe is routinely used as an indica-
tor of gut permeability in animal models [21]. Plasma
concentrations of the probe were then determined by
fluorimetry and used as an indication of intestinal perme-
ability, as described previously [22]. Significant increases
in intestinal barrier dysfunction were detected, compared
to sham-infected mice, when WT (10d PI) and MMP-9−/−
(10d PI) mice were infected with C. rodentium (Figure 2C)
(P< 0.05). However, there were no differences notedFigure 2 MMP-9−/− and WT mice infected with C. rodentium have sim
Representative H & E stained images of colonic tissues demonstrating C. ro
bar, 100 μm. (B) Quantitative analysis shows significant increases in colonic
compared to sham-infected mice. N = 12-18. (C) Fluorometric analysis of a
MMP-9−/− mice in the presence or absence of C. rodentium infection (10d
Sham MMP-9−/−. N = 7-17.between WT and MMP−/− infected groups at 10d PI. At
30d PI, intestinal permeability had returned to baseline
levels in both WTand MMP-9−/− mice.
Immunocytochemistry of sham and C. rodentium-
infected (10d) colon from WT mice revealed localized
expression of MMP-9 (green) primarily at the apical
surface of intestinal epithelium, with more intense
staining in infected mice (Figure 3). No non-specific
binding of anti-MMP-9 antibody was observed in isotype
controls.
C. rodentium infection modulates goblet cells in
colonocytes
Periodic Acid Shiff (PAS) staining was used to assess
the qualitative (Figure 4A) and quantitative (Figure 4B)
changes to goblet cells that occurred during C.
rodentium infection. There were no differences in the
number of positively stained red cells in colonic crypts
from MMP-9+/+ cells and MMP-9−/− mice at 10d PI.
Quantitative analysis of the number of positive PAS
stained cells per crypt showed a significant increase in
MMP-9−/− mice at 30d PI, compared to wild type
infected mice (P< 0.05).ilar histopathology and mucosal barrier dysfunction. (A)
dentium-induced inflammation in MMP-9+/+ and MMP-9−/− mice. Scale
crypt height in MMP-9+/+ and MMP-9−/− mice at 10d and 30d PI,
4 kDa FITC-dextran probe in serum samples obtained from WT and
and 30d PI). *P<0.05 compared to Sham WT; #P<0.05 compared to
Figure 3 MMP-9 expression is increased with C. rodentium infection. Immunohistochemistry shows that MMP-9 distributed throughout the
crypts (green) in uninfected WT mice is localized primarily to the apical surface of intestinal epithelium in C. rodentium-infected (10d) WT mice.
Scale bar, 100 μm.
Figure 4 Post-infectious goblet cell hyperplasia occurs in MMP-9−/− mice. (A) Representative histology demonstrating goblet cells stained
positive (red) for PAS in MMP-9+/+ and MMP-9−/− colonocytes. (B) Quantitative analysis shows similar numbers of goblet cells in WT and MMP-9−/−
mice at 10d PI. A significant increase in goblet cells was observed in MMP-9−/− mice at 30d PI. *P<0.05 compared to WT-infected animals. N = 3–5.
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(IL)-17
To delineate the impact of MMP-9 deficiency on
adaptive immune responses to C. rodentium, qPCR
was employed to measure the transcription of various
pro- and anti-inflammatory cytokines. Uninfected
MMP-9−/− mice had higher mRNA levels of IL-17
than WT animals (P< 0.05) (Figure 5), but not TNFα,Figure 5 MMP-9−/− mice demonstrate elevated baseline IL-17 transcri
thickness distal colons obtained from infected and uninfected WT and MM
FOXP3 and β–actin (housekeeping gene). *P<0.05 compared to Sham WT;IFNγ, IL-4, IL-10 and FOXP3 (P>0.05). At 10 and
30 days PI, mice had significant increases in IL-17,
TNFα and IFNγ (for all P< 0.05), but levels did not
differ between MMP-9−/− and WT mice (P>0.05). At
30 days PI, both groups of mice demonstrated ele-
vated IL-10 and FOXP3 mRNA (for both P< 0.05),
indicating the resolution phase of the infectious
colitis.ption, compared to WT mice. Analysis of mRNA from whole-
P-9−/− mice for the following genes: IL-17, TNFα, IFNγ, IL-4, IL-10,
#P<0.05 compared to Sham MMP-9−/−. N = 6-18.
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Variations in the proportion of C. rodentium in fecal
samples were represented in electropherograms with
each of the graphs signifying one mouse. C. rodentiumFigure 6 MMP-9−/− mice have an altered intestinal microbiome and d
employed to track the colonization of C. rodentium in infected mice by foll
electropherograms (indicated by arrows). (B) Nonmetric multidimensional s
reveals two distinct microbial communities. N = 15-18.was identified in WT (pi= 0.67) and MMP-9
−/− mice
(pi= 0.07) at 10 days PI and undetectable at 30 days PI
(Figure 6A) [9]. This observation prompted an eva-
luation and comparison of the bacterial composition inecreased C. rodentium colonization efficiency. (A) T-RFLP was
owing the presence and intensity of the 118 bp peak on
caling of terminal restriction fragments from WT and MMP-9−/− mice
Table 2 Shannon diversity index and measurement of
Evenness of the fecal microflora prior to and after
challenge with C. rodentium (CR, in wild type (WT) and
MMP-9 gene knockout mice
Experimental group Shannon-seiner diversity Evenness
Sham WT 1.88 ± 0.10 0.81 ± 0.02
CR WT 10d 1.32±0.14* 0.65±0.06*
CR WT 30d 1.67 ± 0.08 0.80 ± 0.02
Sham MMP-9−/− 1.59 ± 0.05 0.81 ± 0.01
CR MMP-9−/− 10d 1.83 ± 0.10 0.87±0.03 Ψ
CR MMP-9−/− 30d 1.70 ± 0.09 0.91±0.01 Ψ
N=3-8 in each experimental group
* p< 0.05 vs WT uninfected and WT 30 days PI
Ψ p< 0.05 vs MMP-9−/− uninfected
Rodrigues et al. BMC Microbiology 2012, 12:105 Page 7 of 13
http://www.biomedcentral.com/1471-2180/12/105stool pellets obtained both before and after the enteric
infection. Peaks from each of the electropherograms
generated were analysed by nonmetric multidimensional
scaling (NMS) to screen for microbial community differ-
ences between the WT and MMP-9 gene knockout mice
(Figure 6B). Multi-response permutation procedure
(MRPP) of NMS scores revealed significantly different
bacterial communities between WT and MMP-9−/− mice
(Table 1). Pair-wise comparisons between experimental
groups also revealed that the microbiota of sham
infected WT mice differed from that of the C. roden-
tium-infected WT 10 day group, while no significant
changes were observed between sham infected MMP-9−/−
and C. rodentium-infected mice. In addition, all other
comparison groups remained unchanged (Table 1).
Infection of WT mice with C. rodentium resulted in a
lower Shannon diversity index (indicative of a less di-
verse bacterial population) and decreased evenness
(reflecting an increase in the dominance of a phylotype)
relative to Sham WT, affirming that C. rodentium be-
came a major component of the detectable gut micro-
biota (Table 2). This correlates with the significant rise
in Enterobacteriaceae in mice 10d PI with C. rodentium
(Figure 7). Contrary to what was seen with WT mice,
MMP-9−/− mice infected with C. rodentium showed no
significant change in the Shannon diversity index at 10d
and 30d PI. A more even spread of phylotypes (higher
evenness; decrease in the dominance of C. rodentium),
was observed in MMP-9−/− mice at both 10d and 30d PI
compared to Sham MMP9−/− (Table 2).
qPCR analysis of stool samples from uninfected ani-
mals showed no marked differences in levels of Ba-
cilli, Bacteroides, Enterobacteriaceae, Firmicutes or
Lactobacilli between uninfected WT and MMP-9−/− mice
(Figure 7). However there was a larger population
of segmented filamentous bacteria in MMP-9−/− mice
(P< 0.05), which have been shown to dramatically impactTable 1 Multi-response permutation procedure (MRPP)
analysis of wild type (WT) and MMP-9−/− mice in the
absence (Sham) and presence of an enteric bacterial
pathogen, C. rodentium (CR)
Experimental group p-value Chance-corrected
within-group
agreement (A)
Sham WT vs. Sham MMP-9−/− 0.00003 0.1739
Sham WT vs. CR WT 10d 0.0039 0.2449
Sham WT vs. CR WT 30d 0.0933 0.0579
CR WT 10d vs. CR WT 30d 0.0643 0.0824
Sham MMP-9−/− vs. CR MMP-9−/− 10d 0.1235 0.1020
Sham MMP-9−/− vs. CR MMP-9−/− 30d 0.3164 0.0121
CR MMP-9−/− 10d vs. CR MMP-9−/− 30d 0.3192 0.0149
N=3-8 in each experimental group.host adaptive immune responses to challenge with
C. rodentium [23]. At 10 days post C. rodentium chal-
lenge, there was an increase in Lactobacilli in MMP-9−/−
mice compared to WT (P< 0.01). Taken together, these
data show that the intestinal microbiome differs between
WTand MMP-9−/− mice, both before and following an in-
fectious challenge.
Discussion
Bioactive MMP-9 is present within the colonic epithe-
lium and becomes localized primarily near the apical
surface of the intestinal epithelium when associated with
C. rodentium infection. Studies have shown that MMP-9
is upregulated in human IBD with acute inflammation
[11,24]. Deletion of MMP-9 in animal models has
proven beneficial in attenuating S. typhimuium and
DSS-induced colonic injury and inflammation [19,25,26].
The effect of MMP-9 on the gut microbiota has not
been previously evaluated. This study shows the contri-
bution of MMP-9 in the pathobiology of C. rodentium
infection and an impact on the composition of the fecal
microbiota. We demonstrate that despite similar C.
rodentium-induced colonic epithelial responses between
WT and MMP-9−/− mice, there is a different microbial
composition between genotypes that results an altered mi-
crobial response following an infectious challenge. These
differences were revealed by nonmetric multidimensional
scaling of terminal restriction fragments. The findings in-
dicate that a difference in genotypes plays a role in influ-
encing the microbiome composition in uninfected mice.
A healthy gut microbiome is maintained through
microbe-microbe and host-microbe interactions. An al-
teration in gut microbe homeostasis is associated with
chronic IBD in humans [1] and with post-infectious IBS
[6]. A change in the microbiome also occurs in response
to infection with the murine-specific pathogen Citrobac-
ter rodentium [21]. The importance of a healthy gut
microbiome is also implicated in toxigenic Clostridium
difficile infection, which is triggered by the loss of
Figure 7 MMP-9−/− mice have a microbiome enriched in segmented filamentous bacteria. qPCR analysis of bacterial 16 s rRNA sequences
specific to the following communities of bacteria: Bacillus, Bacteroides, Enterobacteriaceae, Firmicutes, Lactobacilli/Lactococci, and SFB (“A
immunis”).*P<0.05 compared to Sham WT; #P<0.05 compared to Sham MMP-9−/−. N = 4-11.
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ecological niches previously unavailable following anti-
biotic treatment [27].
Infection with C. rodentium resulted in activation of
MMP-9, as demonstrated by zymography of colonic tis-
sue. The resulting pro-inflammatory response to infec-
tion, including colonic epithelial cell hyperplasia and
barrier dysfunction, was similar irrespective of genotype.Taken together, these findings indicate that increased ex-
pression of colonic MMP-9 following infection with
C. rodentium is not associated with the host pro-
inflammatory immune responses to the enteric pathogen.
Elimination of various factors contributing to innate and
humoral immunity can dramatically alter the gut micro-
biome. Specifically, TLR5-deficient mice develop a mark-
edly different intestinal microbiome, which predisposes the
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impaired innate immune function in T-bet−/−Rag1−/− mice
develop a microbiota which is colitogenic and transfer-
able to WT mice by fecal transplantation [29].
MMP-9 deficiency is associated with altered goblet cell
differentiation, leading to an enrichment of bactericidal
mucins in the intestine of mice treated with dextran so-
dium sulphate and Salmonella typhimurium [26]. This
enrichment in mucus secretion in the lumen could
prove important for reducing nutrients for pathogen
growth and, in turn, lead to altered microbe-microbe
interactions thereby disrupting gut microbe homeostasis
in MMP-9−/− mice. Although there was no difference in
the number of goblet cells present in the colonic crypts
of WT and MMP-9−/− mice at the height of infection
10d PI, delayed changes to the goblet cell population
were observed by 30d PI. This indicates a fundamentally
different innate response to infection between WT and
MMP-9−/− mice which may contribute to an atypical
fecal microbiome in MMP-9−/− mice. Recent evidence
also indicates that MMPs regulate the intercellular ex-
pression of several key mediators of cell-cell binding in-
cluding claudin-5 and occludin [30]. For instance, in the
context of lung injury, the pore-forming cytotoxin α-
hemolysin from Staphylococcus aureus upregulates the
zinc-dependent metalloprotease ADAM10, resulting in
cleavage of E-cadherin and disruption of intercellular
tight junctions [31].
Most MMPs are secreted factors, but many of the pro-
teases localize to cell surfaces where they associate with
and regulate a variety of adhesion molecules, such as
CD44 and β-integrins [32,33]. This indicates that MMPs
could alter the binding efficiency of intestinal bacteria to
host colonocytes, thereby altering the pathobiology of an
infectious colitis. MMP-7 also affects gut microbe
homeostasis through cleavage of reduced cyptdin-4
(r-Crp4), a mouse Paneth cell-derived α-defensin. In an
in vitro model, cleavage of the peptide resulted in
increased survival of Salmonella enterica serovar Typhi-
murium, E. coli ML35, Staphylococcus aureus, Bifidobac-
terium bifidum, Bifidobacterium longum, Lactobacillus
casei, Bacteroides thetaiotaomicron, and Bacteroides vul-
gatus relative to undigested r-Crp4 [34]. Therefore, the
presence of MMPs in the colonic mucosa can mediate
physiological parameters that impact on both gut
homeostasis and host-microbe interactions. Disruption
of these interactions leads to an altered microbial ecol-
ogy and disease [35].
Segmented filamentous bacteria (SFB) "Arthromitus
immunis” [36]; provides mucosal protection against C.
rodentium infection, as well as mediates the production
of the proinflammatory cytokines IL-17 and IL-22 [23].
In the present study, qPCR analysis of the fecal micro-
biome revealed a larger population of SFB and highermRNA levels of IL-17 in MMP-9−/− mice compared to
WT controls, even under baseline conditions. “A. immu-
nis” inhibits colonization of rabbit enteropathogenic
Escherichia coli O103 and protects against subsequent
disease development [37]. In this study, electrophero-
grams showed that C. rodentium became a dominant
component of the detectable microbiota in WT, but not
MMP-9−/− mice. As noted by others [37], this study
shows that the presence of SFB may provide protection
against C. rodentium colonization, although our results
demonstrate that commensal SFB does not offer full
protection against C. rodentium-induced colitis in
C57BL/6 J mice. This observation emphasizes that a
shift in the bacterial population does not have an all-or-
none effect; rather, it produces a graded series of
responses.
In previous studies, infection of C57BL/6 J mice with
C. rodentium reduced fecal microbial diversity and even-
ness due to the dominance of C. rodentium in the gut
microbiome [21]. A similar pattern was observed in the
current study in WT but not MMP-9−/− mice, as the
fecal microbiota of the latter group had no changes in
diversity following infection. Colonization of the cecal
mucosa by the murine pathogen Helicobacter hepaticus
also reduces microbial diversity [38].
The distinct and stable fecal microbiome in MMP-9−/−
mice identified in this study emphasizes that the pres-
ence of MMP-9 in mouse colon supports a microbiome
that is more susceptible to C. rodentium colonization
and reductions in microbial diversity. Given that MMP-
9−/− (B6.FVB(Cg)-Mmp9tm1Tvu/J) mice have a microbiota
that is more resistant to C. rodentium colonization, this
genotype should prove useful for future studies evaluat-
ing the contribution of microbe-microbe interactions to
the pathogenesis of C. rodentium infection and the
maintenance of microbial diversity. The role of other
MMPs in maintaining the fecal microbiota upon infec-
tious challenge will also prove to be of interest in future
experimental studies.
Conclusions
Microbe-microbe and host-microbe interactions are es-
sential for maintaining gut health [1]. Although studies
have shown that expression of matrix metalloproteinase
9 is associated with IBD, the influence of MMP-9 ex-
pression on gut microbial community dynamics has not
been studied in vivo. This work demonstrates that, in a
model of bacterial-induced colitis, the particular micro-
bial community of MMP-9−/− mice contributes to
reduced levels of C. rodentium preventing a reduction in
the microbial diversity associated with infection [21]. An
altered intestinal ecosystem may lead to changes in some
of the protective, metabolic, structural and histological
functions of the gut microbiome [39], which has driven
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describe IBD [4]. Further analysis of the interaction be-
tween the microbiome and other MMPs upregulated in
IBD [1–3,8,12] are required to yield further insight into
microbe-microbe and host-microbe interactions.
Methods
Bacterial strains and growth conditions
C. rodentium, strain DBS 100 (generously provided by
the late Dr. David Schauer, Massachusetts Institute of
Technology, Cambridge, MA) was grown on Luria-
Bertani (LB) agar plates overnight at 37°C, followed by
overnight culture in LB broth at 37°C without shaking,
yielding a final bacterial concentration of approximately
109 colony-forming units (CFU)/mL.
Mouse strains and bacterial infection
Male and female wild-type (C57BL/6 J) and MMP-9−/−
(B6.FVB(Cg)-Mmp9tm1Tvu/J) mice aged 5–6 weeks were
purchased (Jackson Laboratory, Bar Harbour, ME) and
housed in the containment unit of Laboratory Animal
Services at the Hospital for Sick Children in cages con-
taining a maximum of 5 mice per cage. All mice were
allowed free access to food and water (supplied from a
controlled source) for the duration of the study protocol.
Animals were allowed to acclimatize for a period of one
week prior to the start of the treatment protocols. C.
rodentium (108 CFU in 0.1 mL) was administered by
orogastric gavage [40]. Sham animals were challenged
with an equal volume of sterile LB broth. Mice were
infected on day 0 (0d), weighed daily and sacrificed at ei-
ther 10d or 30d post-infection. All experimental proce-
dures were approved by the Hospital for Sick Children’s
Animal Care Committee.
Western blotting and gelatin zymography
Segments of distal colon were collected and homoge-
nized in RIPA buffer (1% Nonidet P-40, 0.5% sodium
deoxylate, 0.1% sodium dodecyl sulfate [SDS] in PBS)
supplemented with 150 mM NaCl, 50 mM sodium
fluoride, 1 mM sodium orthovanadate, 20 μg/mL phe-
nylmethylsulfonyl fluoride, 15 μg/mL aprotinin, 2 μg/
mL leupeptin, and 2 μg/mL pepstatin A (all from
Sigma-Aldrich, Oakville, ON), and stored at −80°C. Pro-
tein was quantified in each sample by using the Brad-
ford assay.
For immunoblotting, samples were loaded at a con-
centration of 25 μg of protein/well in 1x loading buffer
and electrophoresed in 12% SDS polyacrylamide gels
(Bio-Rad, Mississauga, ON) at a constant voltage of
120 V until resolution of the MMP-9 band was
achieved. To verify equivalent samples, mouse mono-
clonal anti-β-actin (1:5,000; Sigma, St. Louis, MO) was
used as a loading control. Gel proteins were transferredat 4°C onto nitrocellulose membranes at 250 mA for
150 min. Membranes were washed in Tris buffered sa-
line (Sigma-Aldrich) and blocked in Odyssey blocking
buffer (Leica, Toronto, ON) for 1 hr at room
temperature. The membrane was incubated with pri-
mary antibody (anti-β-actin (1:5000) [Sigma-Aldrich];
anti-MMP-9 (1:1000) [Abcam, Cambridge, MA]
diluted in Odyssey blocking buffer containing 0.1%
Tween-20 (Od-T) overnight at 4°C. The membrane
was then washed in TBS containing 0.1% Tween-20
(TBS-T), blocked for 1 hr in Od-T containing 1% don-
key serum (Jackson Immunoresearch, West Grove, PA)
and treated with relevant IR-dye-conjugated donkey
secondary antibody (Rockland, Gilbertsville, PA) in
Od-T for 1 hr at room temperature. After washing in
TBS-T, immunoreactivity was visualized using an infra-
red imaging system (Odyssey) with 700 and 800 nm
channels at a resolution of 169 μm (LI-COR Bios-
ciences, Lincoln, NE).
Gelatin zymography was performed by diluting
colonic homogenates in zymogram sample buffer (Bio-Rad)
and electrophoresing the samples in precast 10% SDS-
poly-acrylamide gels with gelatin (Bio-Rad) at 120 V
until resolution was achieved. Gels were removed from
their casings, gently rinsed in ddH2O, and placed onto a
shaker in 1X renaturation buffer (Bio-Rad) for 1 hr,
changing the buffer once at 30 mins. Gels were then
placed in 1X development buffer (Bio-Rad), incubated
at 37°C overnight and stained with Page Blue (Fermen-
tas, Burlington, ON) for 1 hr before destaining in water
for 1 hr and imaging on a Li-Cor Odyssey system.
FITC-dextran permeability assay
Intestinal epithelial barrier function was measured
in vivo using a 4 kDA fluorescein isothiocyanate-dextran
probe (FD4, Sigma-Aldrich, Oakville, ON, Canada) mea-
sured in serum, as previously described [8]. FITC-
dextran serum concentrations were determined by fluor-
ometry (Perkin Elmer, Woodbridge, ON, Canada).
Histology and immunocytochemistry
Distal segments of colon [9] were excised following sac-
rifice, gently scraped to remove fecal material, fixed in
10% neutral-buffered formalin and embedded in paraffin
blocks. Tissue was sectioned at 4 μm thickness and
stained with haematoxylin and eosin. Sections were
visualized on a Leica DMI 6000B microscope using
Leica Application Suite Advanced Fluorescence 2.2.1
software (Leica). Crypt depths were measured on coded
sections by a blinded observer (DMR) using Leica
Image Manager 500 software (Leica). Final crypt mea-
surements per animal represent the average of 10 crypt
lengths per section of tissue from two non-adjacent co-
lonic sections.
Table 3 Mouse primers employed in this study
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tium-infected mice (day 10) were used for immunocyto-
chemical examination of MMP-9 expression and
localization. Briefly, 5μm-thick paraffin-embedded sec-
tions were deparaffinized in citroclear (National Diag-
nostics, Atlants, GA, USA), and rehydrated in graded
concentrations of ethanol. The antigen was exposed by
steaming sections for 30 min in 10 mM citrate buffer
(pH 6.0)/0.05% Triton X-100 (VWR, Mississauga, ON).
Sections were then blocked in 3% bovine serum albumin
(Sigma-Aldich), and incubated with either a polyclonal
anti-MMP-9 antibody (1:200) or a rabbit primary anti-
body (Rb) isotype control (Invitrogen, Burlington, ON)
overnight at 4°C. Sections were then washed in PBS and
incubated with AlexaFluorW488 goat anti-rabbit IgG
(1:400; Invitrogen), stained with DAPI (1:36,000, Invitro-
gen) and mounted onto slides with fluorescence mount-
ing medium (Dako, Burlington, ON). Fluorescence was
visualized on a Leica DM16000B (Leica, Concord, ON)
equipped with a DFC360FX monochromatic camera
(Leica). Leica Application Suite imaging software was
used for all analyses and images recorded at identical
gain settings.
Periodic acid Schiff staining was used to demonstrate
the presence of mucin-containing vacuoles indicative of
goblet cells [41]. Following the Aldrich Periodic Acid-
Schiff (PAS) Staining System (Procedure No. 395,
Sigma), colonic samples were de-paraffinized and oxi-
dized in 0.5% periodic acid for 5 min. Slides were then
rinsed in distilled water, placed in Schiff reagent, washed,
counterstained in Mayer’s hematoxylin, mounted onto
slides and then visualized microscopically. Ten well
oriented crypts per section of distal colon from each ani-
mal were assessed, using coded slides, for numbers of
PAS-positive stained cells per crypt.
qPCR analysis of pro- and anti-inflammatory markers
Full-thickness distal colons were homogenized in Trizol
(Invitrogen, Burlington, ON, Canada) and RNA extracted
using a phenol-chloroform extraction protocol (Invitro-
gen). To eliminate DNA contamination, DNAse A
(Invitrogen) was used, according to the manufacturer’s
instructions. cDNA libraries then were generated using
an iSCRIPT cDNA synthesis kit (Bio-Rad), and subse-
quently amplified by quantitative PCR using SSO Fast
EvaGreen Supermix and a CFX96 C1000 Thermal Cycler
(BioRad). Primers against mouse β-actin (housekeeping
gene), IL-4, IL-10, IL-17α, TNFα, IFNγ and Foxp3
(Table 3) were utilized, as described previously [42].
Gut microbiome analysis
Fecal pellets were collected from mouse colons after ani-
mal sacrifice and stored at −80°C. DNA was extracted
using the QIAamp DNA stool kit (QIAGEN, Toronto,ON), according to the manufacturer’s instructions. The
fecal microbiome was studied in wild-type (WT) and
MMP-9−/− infected and non-infected mice using two
complementary techniques.
For a holistic view of the microbiome structure, terminal
restriction fragment length polymorphism (T-RFLP) was
used to assess evenness and the Shannon-Weiner diversity
index. Briefly, as previously described [21], DNA was
extracted from each individual mouse and quantified
using a NanoDrop 2000c spectrophotometer (Thermo
Scientific, New York, NY). PCR amplification was run in
duplicate for each sample with 8 F and 1492R primers.
Agarose gel electrophoresis was used to purify the sample
and a band at approximately 1.6 kb was excised and puri-
fied using a gel extraction kit (Qiagen, Mississauga, ON).
DNA was digested with MspI (New England Biolabs Inc.,
Pickering, ON) for 30 mins at 37°C and subject to capil-
lary electrophoresis using an ABI 3130 Genetic Analyzer.
Electropherograms were generated from individual mice
and C. rodentium colonization monitored by identifying
and quantifying a 118 bp digested fragment length unique
to C. rodentium. NMS was carried out on terminal restric-
tion fragments using PC-ORD Version 6.0 (MjM Software
Design, Oregon, USA Sørensen (Bray-Curtis) was used as
the distance measure and random starting configurations
were used with 250 runs of real data. The final stress of
the best solution was 10.6, with three dimensions in the
final solution. The Monte Carlo test used 249 randomized
runs and produced a p-value of 0.0040. Multi-response
permutation procedure (MRPP) was used to compare
differences between experimental groups by analysis of
the chance-corrected within group agreement (A) and
p-value [43].
qPCR was used for a reductionist view of specific bacter-
ial communities (Bacilli, Bacteroides, Enterobacteriaceae,
Firmicutes, Lactobacillus, and segmented filamentous bac-
teria) utilizing previously published primers and protocols
[42].
Statistical analyses
Results are expressed as means, +/− standard error of
the mean (SEM). Comparisons were performed between
Rodrigues et al. BMC Microbiology 2012, 12:105 Page 12 of 13
http://www.biomedcentral.com/1471-2180/12/105multiple experimental groups by using either 2-way ana-
lysis of variance (ANOVA) or Student’s t-test, where
indicated. P values of< 0.05 were considered significant.
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